Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05118633Not ApplicableNot Yet Recruiting

Technology Assisted Treatment for Trichotillomania

Role: lead

NCT07224126Not ApplicableRecruiting

Technology Assisted Treatment of Trichotillomania: Open Trial

Role: lead

NCT05829941Not ApplicableUnknown

Technology Assisted Treatment for Binge Eating Behavior

Role: lead

NCT04241120Not ApplicableCompleted

Feasibility Study for Treating Trichotillomania With Wearable Device and App System

Role: lead

All 4 trials loaded